Letters New somatic symptom disorder in DSM-5

Patients won’t be the winners

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2235 (Published 16 April 2013) Cite this as: BMJ 2013;346:f2235
  1. Johanna Ryan, paralegal1
  1. 1Elfenbaum Evers and Amarilio, Chicago, IL 60607, USA
  1. jryan{at}ilcomplaw.com

I can see several potential winners if this category of somatic symptom disorder is accepted.1

Firstly, the manufacturers of “mood stabilisers,” antidepressants, and so on, which are already aggressively marketed to treat physical pain from neurological ailments, arthritis, and traumatic injuries, and pain allegedly caused by depression. There will scarcely …

View Full Text

Log in

Log in through your institution


* For online subscription